news
News
"NeoChord closes on $5.1 million in Series B funding."
August, 2011
"Hopen nabs 25M for Second Fund."
August, 2011
"Case report of a patient in the TACT trial at Heart Centre, Leipzig University published."
Fall, 2011
"NeoChord Enrolls First Patient in European Clinical Trial"
October 28, 2009
"Minnetonka Firm to Test New Heart Valve Repair..."
July 14, 2009
"NeoChord Raises At Least $2.8 million for Mitral Valve Repair Technology"
July 6, 2009
"Start-up raises $1.2M for heart 'strings'"
October 17, 2008
"Clarian Invests in Minnesota Technology Company"
October 7, 2008
"Mayo Clinic + Neochord"
November 12, 2007
Events
NeoChord will be at the EACTS (European Association For Cardio-Thoracic Surgery) Annual Meeting October 27th - 31st, 2012 in Barcelona, Spain
CAUTION: The NeoChord device is an investigational device. Limited by United States law to investigational use.